Skip to main content

Zydus Lifesciences

academics

 

Clinical research courses

  • DEVELOPMENT AND VALIDATION OF STABILITY INDICATING RP-HPLC METHOD FOR ESTIMATION OF TADALAFIL AND DAPOXETINE HCL IN SOLID DOSAGE FORM

    About Authors:
    CHIRAG S. RAJPARA*1, JAWED AKHTAR1, AMIT KHANDHAR2
    1. Department of Quality Assurance, School of Pharmaceutical Sciences, Jaipur National University, Jagatpura, Jaipur-302025, Rajasthan, India.
    2. Zydus cadila pharma, moraiya,ahmedabad.
    *chiragrajpara2601@gmail.com

    ABSTRACT
    * A simple, specific, accurate and stability-indicating reversed phase high performance liquid chromatographic method was developed for simultaneous estimation of Tadalafil and Dapoxetine HCL, Water Symmetry C-18 (150 x 4.6 mm),5 µ and a mobile phase composed of Buffer : Acetonitrile (65:35)

    * The retention time of Tadalafil and Dapoxetine HCL were found to be10.08 and 4.45 min respectively. Linearity was established for Tadalafil and Dapoxetine HCL in the range of 8.0-60 μg/ml and 24.0-180.0 μg/ml respectively. The percentage recovery of Tadalafil and Dapoxetine HCL were found to be in the range of 99.7-100.6% and 98.07-99.09% respectively. The drug was subjected to acid and alkali hydrolysis, oxidation, dry heat and photolytic degradation. The degradation studies indicated, Tadalafil showed degradation in acid and alkali while it was found stable in H2O2, photolytic and in presence of dry heat and Dapoxetine showed degradation in thermal and peroxide while it was found stable in rest of parameters . The degradation products of Tadalafil and Dapoxetine HCL in acidic, alkaline conditions were well resolved from the pure drug with significant differences in their retention time values. This method can be successfully employed for the quantitative analysis of Tadalafil and Dapoxetine HCL in bulk drugs and formulations.

  • Require Manager - SRP (Solvent Recovery) (API - Manufacturing) in Zydus Cadila

  • Wanted Chemist / Sr. Chemist - QC - API in Zydus Cadila - 5 Openings

  • Requirement of Executive / officer - IPR (Intellectual Property) (API - R & D) @ Zydus Cadila

  • Detailed Advertisement of Walk in Interview in Zydus Cadila | Opening in Supervisors / Officers in Production & Packaging areas of Tablets, Capsules, Ointments, Parenterals; Chemist - QA / QC

    Zydus Cadila is one of India's leading healthcare companies and a global healthcare provider with strengths all along the pharmaceutical value chain. The group's state-of-the-art manufacturing infrastructure is spread across five states of Gujarat, Maharashtra, Goa, Himachal Pradesh and Sikkim. Of these, five facilities are USFDA approved.

  • Candidates invited for WALK IN INTERVIEW by ZYDUS CADILA | Require Supervisors/ Officers in Production, Packing, Chemists/ Officers in QA and QC

  • Require Chemist/Sr. Chemist/Officer - QC API - Pharmaceuticals in Zydus Cadila - 4 Openings

  • Work as Program Manager - R&D - API in Zydus Cadila

    Zydus Cadila is a professionally managed public company offering immense opportunities to learn and grow. This ability to evolve, gain new capabilities and raise the bar of excellence forms the heart of our success. We provide an environment where people come and give their best not because they have to, but because they want to. At Zydus we build people to build our business.

  • Cadila Healthcare invites for the post of Chemist/Sr. Chemist/Officer - Production - 3 posts

    Zydus Cadila is a professionally managed public company offering immense opportunities to learn and grow. This ability to evolve, gain new capabilities and raise the bar of excellence forms the heart of our success. We provide an environment where people come and give their best not because they have to, but because they want to. At Zydus we build people to build our business.

  • Job as Group Leader (Dy. Manager / Manager - Research & Development - API) at Zydus Cadila

Subscribe to Zydus Lifesciences